Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
about
Specific activation of leukocyte beta2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the alpha subunit cytoplasmic domainsHuman BCAS3 expression in embryonic stem cells and vascular precursors suggests a role in human embryogenesis and tumor angiogenesisA role for Syk-kinase in the control of the binding cycle of the beta2 integrins (CD11/CD18) in human polymorphonuclear neutrophilsCloning and expression of intercellular adhesion molecule 3 reveals strong homology to other immunoglobulin family counter-receptors for lymphocyte function-associated antigen 1Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytesCharacterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responsesProtection of Candida parapsilosis from neutrophil killing through internalization by human endothelial cellsThe regulation of transendothelial migration: new knowledge and new questionsMonocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractantA binding interface on the I domain of lymphocyte function-associated antigen-1 (LFA-1) required for specific interaction with intercellular adhesion molecule 1 (ICAM-1)Adhesion molecules involved in protein kinase A- and C-dependent lymphocyte adherence to microvascular endothelial cellsDistinct roles for LFA-1 affinity regulation during T-cell adhesion, diapedesis, and interstitial migration in lymph nodes.ICAM-2 facilitates luminal interactions between neutrophils and endothelial cells in vivoExpression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells.Adhesion of T and B lymphocytes to mouse atherosclerotic aortas: association with lesion topology and VCAM-1 expression.ICAM-2 expression mediates a membrane-actin link, confers a nonmetastatic phenotype and reflects favorable tumor stage or histology in neuroblastoma.ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling.Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assayHuman/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules.FRET based quantification and screening technology platform for the interactions of leukocyte function-associated antigen-1 (LFA-1) with intercellular adhesion molecule-1 (ICAM-1).An atomic resolution view of ICAM recognition in a complex between the binding domains of ICAM-3 and integrin alphaLbeta2.A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2RUNX3 regulates intercellular adhesion molecule 3 (ICAM-3) expression during macrophage differentiation and monocyte extravasation.Analysis of the binding site on intercellular adhesion molecule 3 for the leukocyte integrin lymphocyte function-associated antigen 1.Homeostatic control of lymphocyte survival: potential origins and implications.N-glycosylation of ICAM-2 is required for ICAM-2-mediated complete suppression of metastatic potential of SK-N-AS neuroblastoma cellsOrganization of the integrin LFA-1 in nanoclusters regulates its activity.Escherichia coli induces transuroepithelial neutrophil migration by an intercellular adhesion molecule-1-dependent mechanismLeukocyte cell adhesion proteins: from molecular dissection to clinical applications.Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms.The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stromaHeterogeneity of endothelial cells from different organ sites in T-cell subset recruitment.Hydrogen peroxide-induced endothelial retraction is accompanied by a loss of the normal spatial organization of endothelial cell adhesion molecules.Helicobacter pylori. New diagnostic tools. Clinical and experimental studies on local and systemic immune response. Minireview based on a doctoral thesis.Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease.An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration.Prevention of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice by treatment with antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1.The cytoplasmic domain of the integrin lymphocyte function-associated antigen 1 beta subunit: sites required for binding to intercellular adhesion molecule 1 and the phorbol ester-stimulated phosphorylation site.Lymphocyte adhesion through very late antigen 4: evidence for a novel binding site in the alternatively spliced domain of vascular cell adhesion molecule 1 and an additional alpha 4 integrin counter-receptor on stimulated endothelium.
P2860
Q22009172-8E276FA9-AC36-4D42-A2ED-A7BAD6C2975BQ24301245-A17B10E9-7A3D-4739-8109-9180F3CB9C98Q24311920-20D18EA8-CE22-4B1B-AA8C-88FBFFD6C65DQ24323229-422E1073-1776-42FC-B42E-FDFD1B4AF2A9Q24675511-869C97C7-908D-4D8C-806A-9BFE2AB03F39Q24680170-C51BFE10-0AC4-477C-BD06-05C32E565FABQ27311102-351A228E-B65D-4379-BB5F-E72856277602Q28084349-91EE34C2-D3BB-4FFC-891D-66FE8DFEC150Q28252699-5AFBE059-1F66-4673-8F03-35FC94213DAFQ28295590-CEA72D09-65B5-419F-81A1-591D716EB599Q28572475-DE5CF885-D97C-4653-8DF0-73C2B92C5261Q30493442-B93974C3-6753-4ACD-9010-2398EC16D9E7Q30577464-90E0A593-E96C-4C3B-A372-E4D48AC1F4BEQ33190433-8DB2A741-C4B0-4075-9647-D55696488FD3Q33226674-5169554C-8163-42CF-A280-071C67AAD8EFQ33382115-187DCD3E-BEE9-4B3D-AC53-80034A0DB85DQ33587422-51343CDF-1F0A-4D85-8B56-2A53A4C12522Q33783773-CD8739E5-58CC-4420-AD21-D9A4B5A5A0DDQ33893217-DC3AF8FE-C0B9-4156-9021-D26EA325DE58Q33916422-241209DD-C992-42B0-9C1B-17BFD7B17F8AQ33927511-3AA34EFA-777F-4D3E-AEF9-6E126C5DEB9CQ34185817-8F60AFCD-CF32-4C1A-817E-B32AC0AAE6AFQ34221376-942B05DE-3FB0-42B8-B751-66C589FA6CF2Q34316037-9C55C6A9-04D8-4011-8B81-5F9242AD1008Q34658353-DD1B28DB-B830-441B-8B68-720E816D025FQ34743122-43FC47B9-F418-4B3C-828D-FCA528F8F7F6Q35128243-A47F6B39-4B87-4B0C-AFF9-FA4409412406Q35444967-966BE033-F423-4FD8-A8FB-11DBB5CF5165Q35454934-8BD1F37E-3DE1-4A9E-BF58-4AD8325CDD00Q35599624-84472549-B22D-4393-A906-112EE97458C3Q35604062-CEF7CDE2-9751-48FD-A41F-47F302FEFC89Q35604780-1BD46C3D-3686-45EB-A7C2-84FD8ECBEC66Q35749118-2A32BCD5-9397-4645-9634-B0910FA1BEB4Q35798459-BB7BB189-408C-4EFA-9952-989CC40F368DQ35827851-335F7358-A85C-49DF-A6F4-7D059007A380Q35833354-135DF4AC-5096-4AC6-9EEC-E13F6EC7E2F1Q35834078-E34098D2-CE18-4D8D-A584-7551B566AA68Q36019153-11ECF81E-4D65-4D1C-B63A-95E71D50CC7CQ36230577-72A42739-1477-4DA0-BA14-46653CE222D1Q36231422-3A1FCD73-52E5-45D2-86BA-2265EBB20CD4
P2860
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
description
1991 nî lūn-bûn
@nan
1991 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
@ast
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
@en
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
@nl
type
label
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
@ast
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
@en
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
@nl
prefLabel
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
@ast
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
@en
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
@nl
P2093
P2860
P356
P1476
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
@en
P2093
A R de Fougerolles
R Schwarting
S A Stacker
T A Springer
P2860
P304
P356
10.1084/JEM.174.1.253
P407
P577
1991-07-01T00:00:00Z